Monoclonal Gammopathy of Undetermined Significance
Information
- Disease name
- Monoclonal Gammopathy of Undetermined Significance
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04920084 | Active, not recruiting | N/A | A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) | June 3, 2021 | June 2025 |
| NCT03327597 | Active, not recruiting | N/A | Iceland Screens, Treats or Prevents Multiple Myeloma | September 1, 2016 | September 1, 2026 |
| NCT03855878 | Active, not recruiting | Observation of the Incidence and Natural History of MGUS in Patients Undergoing Weight Reduction Surgery | November 8, 2018 | August 8, 2024 | |
| NCT00025415 | Completed | Phase 1 | Imatinib Mesylate in Treating Patients With Advanced Cancer and Liver Dysfunction | August 2001 | |
| NCT04439006 | Completed | Phase 1 | Ibrutinib for the Treatment of COVID-19 in Patients Requiring Hospitalization | October 23, 2020 | September 20, 2022 |
| NCT04615572 | Completed | Screening to Improve Survival in AL Amyloidosis | August 28, 2020 | July 6, 2023 | |
| NCT00919139 | Completed | S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS. | November 2003 | November 2010 | |
| NCT01219010 | Completed | Phase 1 | A Study Evaluating the Effects of Siltuximab on the Heart in Patients With Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Indolent Multiple Myeloma | October 2010 | March 2014 |
| NCT01237054 | Completed | Phase 2 | Imaging in MGUS, SMM and MM | October 17, 2010 | August 9, 2011 |
| NCT00099047 | Completed | Phase 2 | Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma | November 2004 | November 2008 |
| NCT01588015 | Completed | Phase 1 | Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant | October 29, 2012 | February 2, 2024 |
| NCT01955395 | Completed | N/A | Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma | October 2013 | September 2016 |
| NCT05969821 | Not yet recruiting | Clonal Hematopoiesis of Immunological Significance | September 2023 | September 2043 | |
| NCT04702932 | Not yet recruiting | Establishment of Genomic, Transcriptomic and Functional Characteristics of Tumor Cells in Hyperinflammatory Hemopathies | September 1, 2021 | September 1, 2036 | |
| NCT06383143 | Recruiting | Promoting Diagnosis and Management of AL in Italy (ProDigALIty) | May 1, 2023 | May 1, 2025 | |
| NCT01408225 | Recruiting | Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource | March 17, 2011 | March 2050 | |
| NCT02726750 | Recruiting | Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma | December 14, 2015 | April 30, 2026 | |
| NCT03119883 | Recruiting | N/A | Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma | June 2, 2017 | June 30, 2024 |
| NCT04114084 | Recruiting | Sleep Apnea in Patients With MGUS and MM | May 23, 2019 | May 23, 2024 | |
| NCT04850846 | Recruiting | Phase 2 | Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma | April 27, 2021 | July 31, 2025 |
| NCT05136807 | Recruiting | Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies | June 7, 2016 | February 2, 2027 | |
| NCT05361694 | Recruiting | Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions | April 12, 2022 | July 1, 2027 | |
| NCT05640843 | Recruiting | N/A | A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM) | November 29, 2022 | November 2026 |
| NCT05831358 | Recruiting | N/A | Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program | June 16, 2023 | April 30, 2025 |
| NCT05965115 | Recruiting | The China M-protein Screening Project in First-degree Relatives of Myeloma Patient - The CHAPERONE Study | July 2023 | August 2035 | |
| NCT06046287 | Recruiting | Phase 2 | Daratumumab for Polyneuropathy Associated With MGUS | June 2024 | December 2026 |
| NCT04731844 | Recruiting | Phase 2 | Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer | December 14, 2021 | May 31, 2024 |
| NCT00899353 | Terminated | Phase 2 | Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM) | August 2008 | October 2012 |
| NCT01079429 | Terminated | Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM. | January 12, 2009 | September 2019 | |
| NCT01109407 | Terminated | Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM) | April 22, 2010 | February 25, 2021 | |
| NCT05114109 | Unknown status | Phase 2 | Isatuximab in Type I Cryoglobulinemia | November 1, 2021 | December 31, 2023 |
| NCT04727294 | Unknown status | MGUS, SMM, and MM Patient Experience With Coronavirus 19 (COVID-19) Survey | January 22, 2021 | December 2021 | |
| NCT02298816 | Withdrawn | B-Cell Hematologic Malignancy Vaccination Registry | August 2014 | December 2025 | |
| NCT01571726 | Withdrawn | Phase 2 | Imaging Studies and the Development of Multiple Myeloma | March 27, 2012 | April 23, 2014 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D008998